跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,905 条关于
“David Ricks”
全部
1,905
临床试验
324
药物
12
机构
79
资讯
1,490
去年
Eli Lilly CEO David Ricks Tops Pharma Executive Compensation at $29.2 Million in 2024
去年
Eli Lilly's Zepbound Anticipates Approval in Japan by Mid-2025
上个月
Eli Lilly CEO Seeks New Deal to List Mounjaro on Australia's PBS Amid Pricing Standoff
去年
Eli Lilly Anticipates Orforglipron Approval for Weight Loss by Early 2026
8个月前
Eli Lilly Secures $6.5 Billion Houston Manufacturing Plant with Major Tax Incentives
去年
Eli Lilly to Launch Zepbound Advertising Campaign Amidst Growing Market Share
9个月前
Eli Lilly Commits $40 Million to Indiana University for AI-Enhanced Clinical Trial Infrastructure
去年
Eli Lilly to Explore Zepbound for Alcohol and Drug Addiction Treatment
去年
Eli Lilly Invests $4.5 Billion in Advanced Drug Manufacturing Facility
去年
Lilly's Oral GLP-1 Orforglipron Shows Promising Results in Phase 3 Trial
第 1 页,共 149 页
上一页
下一页